Neuraxis, Inc (NRXS): Cost of Revenue
$562.9K
Year ended 2025-12-31
$767.7K
Trailing 12 months to 2026-06-30
+23.7%
3-year compound annual growth
| Period ended | Cost of Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $562.9K | +55.5% | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | $362.0K | +19.3% | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | $303.3K | +2.1% | 2025-03-20, From 2023-01-01 |
| 2022-12-31 | $297.1K | n/a | 2024-04-16, From 2022-01-01 |
Cost of Revenue at similar companies
| Company | Year ended | Cost of Revenue | Change YoY |
|---|---|---|---|
| Neuraxis, Inc (NRXS) | 2025-12-31 | $562.9K | +55.5% |
| ADM Tronics Unlimited, Inc. (ADMT) | 2026-03-31 | $1.99M | +10.6% |
| Hongchang International Co., Ltd (HCIL) | 2024-12-31 | $2.69M | +3.0% |
| Nuwellis, Inc. (NUWE) | 2025-12-31 | $3.15M | +2.7% |
| Escalon Medical Corp (ESMC) | 2025-06-30 | $6.54M | -4.4% |
| CapsoVision, Inc (CV) | 2025-12-31 | $6.38M | +18.6% |
| Hyperfine, Inc. (HYPR) | 2025-12-31 | $6.81M | -2.7% |
| Guided Therapeutics Inc (GTHP) | 2025-12-31 | $196.0K | n/m |
| QT Imaging Holdings, Inc. (QTI) | 2025-12-31 | $10.34M | +361.9% |
Compare NRXS, ADMT, HCIL, NUWE side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗